ORKA Sale Disclosure
Quinlan Paul T · SEC Form 4 · Filed Sep 15, 2026
Sale
Calculated transaction value
$99.44K
Quinlan Paul T General Counsel
ORKA
Oruka Therapeutics
ORKA
Transaction date
Sep 15, 2026
Public filing date
Sep 15, 2026
Filing lag
Filed same day
ORKA daily price context
Close on/before transaction
$92.2
Sep 15, 2026
Close before public filing
$95.93
Sep 14, 2026
Return since public filing
-2.48%
Through Sep 16, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 1,039 shares @ $95.71
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0000907654-26-000095
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$99.44K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Oruka Therapeutics, Inc. ORKA Current | Sale | Sep 15, 2026 | $99.44K |